244 related articles for article (PubMed ID: 26192403)
1. Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua.
Moll G; Ignatowicz L; Catar R; Luecht C; Sadeghi B; Hamad O; Jungebluth P; Dragun D; Schmidtchen A; Ringdén O
Stem Cells Dev; 2015 Oct; 24(19):2269-79. PubMed ID: 26192403
[TBL] [Abstract][Full Text] [Related]
2. Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.
Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
Stem Cells Transl Med; 2018 Apr; 7(4):325-331. PubMed ID: 29533533
[TBL] [Abstract][Full Text] [Related]
3. Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner.
Erkers T; Nava S; Yosef J; Ringdén O; Kaipe H
Stem Cells Dev; 2013 Oct; 22(19):2596-605. PubMed ID: 23701127
[TBL] [Abstract][Full Text] [Related]
4. Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease.
Ringdén O; Sadeghi B
Stem Cells; 2024 Apr; 42(4):291-300. PubMed ID: 38204331
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients.
Kaipe H; Carlson LM; Erkers T; Nava S; Molldén P; Gustafsson B; Qian H; Li X; Hashimoto T; Sadeghi B; Alheim M; Ringdén O
Stem Cells Dev; 2015 Jun; 24(12):1471-82. PubMed ID: 25658253
[TBL] [Abstract][Full Text] [Related]
6. Human decidual stromal cells secrete C-X-C motif chemokine 13, express B cell-activating factor and rescue B lymphocytes from apoptosis: distinctive characteristics of follicular dendritic cells.
Muñoz-Fernández R; Prados A; Leno-Durán E; Blázquez A; García-Fernández JR; Ortiz-Ferrón G; Olivares EG
Hum Reprod; 2012 Sep; 27(9):2775-84. PubMed ID: 22718279
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.
Ringdén O; Gustafsson B; Sadeghi B
Front Immunol; 2020; 11():567210. PubMed ID: 33193339
[TBL] [Abstract][Full Text] [Related]
8. Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation.
Aronsson-Kurttila W; Baygan A; Moretti G; Remberger M; Khoein B; Moll G; Sadeghi B; Ringdén O
Acta Haematol; 2018; 139(2):106-114. PubMed ID: 29408819
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells.
Sadeghi B; Moretti G; Arnberg F; Samén E; Kohein B; Catar R; Kamhieh-Milz J; Geissler S; Moll G; Holmin S; Ringdén O
Front Immunol; 2019; 10():2685. PubMed ID: 31803191
[TBL] [Abstract][Full Text] [Related]
10. Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy.
Gleeson BM; Martin K; Ali MT; Kumar AH; Pillai MG; Kumar SP; O'Sullivan JF; Whelan D; Stocca A; Khider W; Barry FP; O'Brien T; Caplice NM
Stem Cells; 2015 Sep; 33(9):2726-37. PubMed ID: 25969127
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
Ringdén O; Moll G; Gustafsson B; Sadeghi B
Front Immunol; 2022; 13():839844. PubMed ID: 35371003
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease.
Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Klingspor L; Westgren M; Mattsson J; Ringdén O
Biol Blood Marrow Transplant; 2019 Oct; 25(10):1965-1969. PubMed ID: 31173898
[TBL] [Abstract][Full Text] [Related]
13. Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy.
Liao L; Shi B; Chang H; Su X; Zhang L; Bi C; Shuai Y; Du X; Deng Z; Jin Y
Theranostics; 2017; 7(1):106-116. PubMed ID: 28042320
[TBL] [Abstract][Full Text] [Related]
14. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
15. Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells.
Sadeghi B; Ersmark B; Moretti G; Mattsson J; Ringdén O
Int J Hematol; 2020 Apr; 111(4):591-594. PubMed ID: 31853810
[TBL] [Abstract][Full Text] [Related]
16. Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells.
Pilz GA; Ulrich C; Ruh M; Abele H; Schäfer R; Kluba T; Bühring HJ; Rolauffs B; Aicher WK
Stem Cells Dev; 2011 Apr; 20(4):635-46. PubMed ID: 21047215
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation.
Kim JW; Ha KY; Molon JN; Kim YH
Spine (Phila Pa 1976); 2013 Aug; 38(17):E1065-74. PubMed ID: 23629485
[TBL] [Abstract][Full Text] [Related]
18. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
